U-Blot® Research Grade BiciromabCat. No. WA2524$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade BiciromabCat. No. WA2524
U-Blot® Research Grade BHQ880Cat. No. WA2523
U-Blot® Research Grade BezlotoxumabCat. No. WA2522
U-Blot® Research Grade BezetabartCat. No. WA2521
U-Blot® Research Grade bezeotermin alfaCat. No. WA2520
U-Blot® Research Grade BexmarilimabCat. No. WA2519
U-Blot® Research Grade BexatamigCat. No. WA2518
U-Blot® Research Grade BevifimodCat. No. WA2517
U-Blot® Research Grade BevacizumabCat. No. WA2516
U-Blot® Research Grade betinukibartCat. No. WA2515
U-Blot® Research Grade BetifisolimabCat. No. WA2514
U-Blot® Research Grade besufetamigCat. No. WA2513